Literature DB >> 10354919

[Palpable migratory acriform erythema and lymphocytic infiltration of the skin--different presentations of the same entity?].

A Steinmann1, M Gummer, M Agathos, R Breit.   

Abstract

Palpable arciform migratory erythema of Clark (PAME) has been described as a rare member in the group of T-cell pseudolymphoma. The clinical picture of infiltrated annular erythema developing into large migrating lesions with the trunk as predilection site is distinctive from other pseudolymphomas. Because of the very similar histology and immunohistochemistry in comparison to the more frequent lymphocytic infiltration of the skin of Jessner and Kanof (LIS) doubts have been raised about the existence of PAME as an unique entity. A 46-year old patient presented with the typical picture of PAME on his trunk while showing typical lesions of LIS on his neck and face. Both diseases showed synchronous intermittent remissions in response to different therapeutic modalities. Multiple biopsies were subsequently performed and histological, immunohistochemical and molecular biological examinations did not reveal relevant differences between PAME and LIS in this patient. We conclude that the findings in this key case suggest that the T-cell pseudolymphoma PAME is not an unique entity, but a special clinical presentation of LIS.

Entities:  

Mesh:

Year:  1999        PMID: 10354919     DOI: 10.1007/s001050050900

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  3 in total

1.  [Annular erythematous plaques].

Authors:  C Dullweber; A Körber; J Dissemond
Journal:  Hautarzt       Date:  2006-02       Impact factor: 0.751

2.  [Palpable arciforme migratory erythema].

Authors:  G Wagner; S Bartsch; C Rose; M M Sachse
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

3.  Possibly drug-induced palpable migratory arciform erythema.

Authors:  Fernando Luiz Teixeira Dantas; Neusa Yuriko Sakai Valente; Isis Suga Veronez; Priscila Kakizaki; Juliana Ribeiro Leitão; Rafael Cavanellas Fraga
Journal:  An Bras Dermatol       Date:  2015 May-Jun       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.